WL
Wei-Ting Lu
University of Oxford, The Francis Crick Institute, University of Sheffield Medical School, University of Sheffield, University College London
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Cancer Genomics and Diagnostics · DNA Repair Mechanisms · Lung Cancer Treatments and Mutations
0000-0002-1405-4806
Employment
-
University of Oxford Group Leader2025 - Present
-
The Francis Crick Institute Visting Scientist2025 - Present
-
University College, London Postdoctoral researcher2025 - 2025
-
The Francis Crick Institute Postdoc2018 - 2025
-
Massachusetts Institute of Technology David H Koch Institute for Integrative Cancer Research Cambridge (MA) Visiting Postdoctoral Scientist2013 - 2013
-
MRC Toxicology Unit Invesitgator Scientist2010 - 2018
Education
-
University of Sheffield Medical School PhD2006 - 2010
- 2003 - 2006
Projects & Funding
Projects & funding information is unavailable.
Publications (48)
- Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome Save
- DNA methylation cooperates with genomic alterations during non-small cell lung cancer evolution Save
- Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma Save
- TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signalling Save
- Replication timing alterations are associated with mutation acquisition during breast and lung cancer evolution Save
- Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx (Nature, (2023), 616, 7957, (525-533), 10.1038/s41586-023-05783-5) Save
- MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution Save
- Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling Save
- Origins and impact of extrachromosomal DNA Save
- Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models Save
- The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma Save
- The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance Save
- Antibodies against endogenous retroviruses promote lung cancer immunotherapy Save
- Body composition and lung cancer-associated cachexia in TRACERx Save
- Evolutionary characterization of lung adenocarcinoma morphology in TRACERx Save
- Genomic–transcriptomic evolution in lung cancer and metastasis Save
- Lung adenocarcinoma promotion by air pollutants Save
- The evolution of lung cancer and impact of subclonal selection in TRACERx Save
- The evolution of non-small cell lung cancer metastases in TRACERx Save
- Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA Save